参考文献/References:
[1] Olen E, Klinck GH. Hyperthyroidism and thyroid cancer[J].Arch Pathol,1966,81(6):531-535.
[2] Kunjumohamed FP, Al-Busaidi NB, Al-Musalhi HN,et al. The prevalence of thyroid cancer in patients with hyperthyroidism[J].Saudi Med J,2015,36(7):874-877. DOI:10.15537/smj.2015.7.11463.
[3] Wei S, Baloch ZW, LiVolsi VA. Thyroid carcinoma in patients with Graves' disease: an institutional experience[J].Endocr Pathol,2015,26(1):48-53. DOI:10.1007/s12022-014-9343-6.
[4] Hayes FJ, Sheahan K, Heffernan A,et al. Aggressive thyroid cancer associated with toxic nodular goiter[J].Eur J Endocrinol,1996,134(3):366-370.
[5] 胡作军,王深明,常光其,等.原发性甲状腺功能亢进症合并甲状腺癌[J].中国实用外科杂志,2000,20(6):40-41. DOI:10.3321/j.issn:1005-2208.2000.06.018.
[6] 黄华. 原发性甲状腺功能亢进症合并甲状腺癌的临床特点分析[J]. 中国医药指南,2008,6(4):31-32.DOI:10.3969/j.issn.1671-8194.2008.07.016.
[7] 廖辉军,常实,董超,等.30例原发性甲状腺功能亢进症合并甲状腺癌临床特征分析[J].中华内分泌外科杂志,2013,7(1):50-53. DOI:10.3760/cma.j.issn.1674-6090.2013.01.019.
[8] Klang K, Kamaya A, Tahvildari AM,et al. Atypical thyroid cancers on sonography[J].Ultrasound Q,2015,31(1):69-74. DOI:10.1097/RUQ.0000000000000079.
[9] Bartalena L, Baldeschi L, Boboridis K,et al. The 2016 European Thyroid Association/European Group on Graves' orbitopathy guidelines for the management of Graves' orbitopathy[J]. Eur Thyroid J,2016,5(1):9-26. DOI:10.1159/000443828.